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Summary
The recently discovered mitochondrial calcium uniporter
(MCU) promotes Ca2+ accumulation into the mitochondrial
matrix [1, 2].We identified in silicomiR-25 as a cancer-related
MCU-targeting microRNA family and demonstrate that its
overexpression in HeLa cells drastically reduces MCU levels
and mitochondrial Ca2+ uptake, while leaving other mito-
chondrial parameters and cytosolic Ca2+ signals unaffected.
In human colon cancers and cancer-derived cells, miR-25
is overexpressed and MCU accordingly silenced. miR-25-
dependent reduction of mitochondrial Ca2+ uptake corre-
lates with resistance to apoptotic challenges and can
be reversed by anti-miR-25 overexpression. Overall, the
data demonstrate that microRNA targeting of mitochondrial
Ca2+ signaling favors cancer cell survival, thus providing
mechanistic insight into the role of mitochondria in
tumorigenesis and identifying a novel therapeutic target in
neoplasia.
Results and Discussion
miR-25 Downregulates MCU and Protects from
Ca2+-Dependent Apoptosis
In the last two decades, mitochondrial Ca2+ homeostasis
has been shown to participate in the control of the intrinsic
pathway of apoptosis and to be influenced by oncogenes
[3–6], thus suggesting that it is a signaling checkpoint in tumor-
igenesis. However, direct evidence and mechanistic insight
were still lacking. The recent identification of themitochondrial
Ca2+ channel (mitochondrial calcium uniporter, MCU) [1, 2] and
of the associated regulator MICU1 (also known as CBARA1) [7]
now allow molecular investigation of the process, including
the regulation of their expression by microRNAs (miRNAs).
miRNAs are a class of small (19–25 nt), noncoding regulatory
RNAs that regulate gene expression, causing target mRNA*Correspondence: paolo.pinton@unife.itdegradation or suppressing mRNA translation [8]. In human
cancers, specific miRNAs are up- or downregulated, with
consequent alteration in the expression of target proteins
[9, 10].
By filtering the output of four target prediction algorithms
(TargetScan [11], MicroT [12], MicroCosm [13], and miRanda
[14]; see Table S1 available online), we identified five cancer-
related miRNA families (miR-15, miR-17, miR-21, miR-25,
and miR-137) that could be predicted to target MCU and/or
MICU1. We thus tested their effect on mitochondrial Ca2+
homeostasis by expressing them in HeLa cells and measur-
ing mitochondrial [Ca2+] with a targeted aequorin-based
Ca2+ probe (mtAEQ) [15]. The data (Figure 1A) showed that
only miR-25 caused a marked reduction in the [Ca2+]m rise
evoked by cell stimulation with 100 mM histamine, an agonist
coupled to the generation of inositol 1,4,5-trisphosphate
(InsP3) and the release of Ca
2+ from the endoplasmic reticulum
(ER). Accordingly, overexpression of an anti-miR-25 increases
the mitochondrial Ca2+ uptake to agonist stimulation (Fig-
ure S1A), with a slight decrease in cytosolic [Ca2+] ([Ca2+]c),
probably due to increased Ca2+ clearance by mitochondria
(Figure S1B).
The effects were predicted to depend on MCU downre-
gulation. Indeed, the bioinformatics analysis of the 1,896 nt
30 UTR of MCU revealed a 100% match target seed sequence
for miR-25 at nt 1075–1081, highly conserved across seven
species (Figure 1B), and insertion of the 759 nt 30 UTR of
MCU (but not of the 569 nt 30 UTR of MICU1) downstream
of the luciferase gene in a reporter plasmid led to signifi-
cant miR-25-dependent decrease of reporter activity (Fig-
ures S1C and S1D). We thus tested MCU expression by
immunoblotting and detected a marked reduction in the
protein level upon miR-25 overexpression (Figure 1C) and
an increase in anti-miR-25-expressing cells (Figure S1E).
As expected, MCU mRNA abundance was significantly
decreased by miR-25 (Figure 1D), whereas anti-miR-25 in-
creased it (Figure S1F). MCU downregulation was also evident
using an immunofluorescence technique: Figure S1G shows
that miR-25 expression drastically decreased MCU antibody
reactivity.
The effect of miR-25 is shared by the other members of the
miRNA family: miR-92a and miR-363 target MCU mRNA and
reduce MCU protein levels and, accordingly, inhibit mitochon-
drial Ca2+ uptake, without affecting [Ca2+]c and [Ca
2+]er (data
not shown).
We investigated whether miR-25-dependent reduction in
mitochondrial Ca2+ uptake correlates with increased resis-
tance to apoptotic challenges. Microscopy counts of cell
viability after treatment with H2O2, C2-ceramide, or stauro-
sporine (STS) revealed that miR-25-expressing HeLa cells
were strongly protected from death caused by C2-ceramide
and H2O2 (Figure 1E), apoptotic challenges for which mito-
chondrial Ca2+ loading acts as a sensitizing factor [16–18],
whereas the sensitivity to STS was unaffected. Accordingly,
PARP and caspase-3 cleavage upon C2-ceramide treatment
were markedly reduced in miR-overexpressing cells (Fig-
ure 1F). These results were also confirmed by cellular positivity
to the apoptotic marker annexin V (Figure S1H).
Figure 1. miR-25 Reduces [Ca2+]m and Protects
from Apoptosis by Downregulation of MCU
mRNA and Protein Levels
(A) Mitochondrial and Ca2+ homeostasis in HeLa
cells after expression of different miRNAs.Where
indicated, mitochondrially targeted aequorin
(mtAEQmut)-transfected cells were treated with
100 mM histamine (Hist.). Mitochondrial Ca2+
concentration ([Ca2+]m) peaks: negative control
(Ctrl miR): 88.92 6 10.05 mM; miR-15: 84.47 6
9.96 mM; miR-17: 77.49 6 13.23 mM; miR-21:
98.32 6 11.09 mM; miR-25: 31.64 6 5.06 mM;
miR-137: 88.52 6 17.12 mM. miR-25 induces an
w65% reduction of Ca2+ response. n = 18 inde-
pendent experiments.
(B) The miR-25 seed sequence and its target in
seven species; its target site resides at nt 1060–
1082 of theMCU 30 UTR. Themiddle seven nucle-
otides of miR-25 and its target region have been
highlighted.
(C) Immunoblot for MCU andMICU1 after miR-25
expression in HeLa cells. Quantification of MCU
protein is reported.
(D) MCU mRNA expression was assessed by
quantitative real-time PCR in HeLa cells trans-
fected with miR-25 or Ctrl miR. GAPDH expres-
sion was used to normalize MCU expression
results for each sample. miR-25-enforced ex-
pression caused a 30% decrease in MCU
mRNA levels, as compared to control transfected
cells. n = 3 independent experiments.
(E) Microscopy counts of cell viability after treat-
ment with hydrogen peroxide (H2O2; 500 mM for
2 hr) and C2-ceramide (C2-cer.; 40 mM for 2 hr)
revealed that miR-25-expressing HeLa cells
were protected from apoptosis, as compared to
control (Ctrl miR). The number of living cells after
staurosporine (STS; 10 mM for 1 hr) treatment
appears unaffected by miR-25 expression. n = 3
independent experiments.
(F) Immunoblot shows reduced levels of cleaved
PARP and cleaved caspase-3 in miR-25-ex-
pressing HeLa cells after treatment with C2-ce-
ramide (C2-cer.; 40 mM for 2 hr).
See also Figure S1. In this and following figures,
experiments are representative of more than
three trials, and conditions are given in Experi-
mental Procedures. *p < 0.05; error bars corre-
spond to mean 6 SEM.
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We then proceeded to rule out that the effect on [Ca2+]m was
secondary to alterations of global Ca2+ signaling patterns or
to morphological or functional dysregulation of mitochondria.
On the former aspect, we investigated the cytosolic [Ca2+]
changes and the state of filling and release kinetics of the
ER. The results showed that miR-25, when expressed in
HeLa cells, caused no difference in the amplitude of the
[Ca2+]c rise evoked by histamine (Figure 2A), nor in the steady
state [Ca2+]er or in the release caused by the agonist (Fig-
ure 2B). Thus, the effect of miR-25 on Ca2+ homeostasis is
exclusively mitochondrial.
We then investigated the mitochondrial membrane potential
(DJm), the driving force for Ca2+ accumulation, and the
morphology of mitochondria, i.e., both the contacts with the
ER (which were shown to be a critical determinant of rapid
Ca2+ transfer between the two organelle [19–21]) and the
formation of largely interconnected tubules, which favors
Ca2+ diffusion within mitochondria. On the former aspect,measurements with the DJm-sensitive fluorescent dye tetra-
methylrhodamine methyl ester (TMRM) revealed no difference
between miR-overexpressing and control HeLa cells (Fig-
ure 2C). As to morphology, mitochondrial labeling with the
fluorescent probe mtDsRed showed that miR-25 overexpres-
sion causes no significant difference in mitochondrial volume
or number (Figure 2D). Similarly, cotransfection with mtDsRed
and an ER-targeted GFP showed no difference in the number
of contact sites (Figure 2D, contact sites in white).
Overall, the data reveal that the [Ca2+]m reduction caused by
miR-25 should be ascribed to reduction of mitochondrial Ca2+
uptake through MCU. To further confirm this notion, we
measured mitochondrial Ca2+ accumulation in permeabilized
cells. For this purpose, HeLa cells were perfused with a solu-
tion mimicking the intracellular milieu (IB), supplemented
with 2 mM EGTA, and permeabilized with digitonin for 1 min.
The perfusion buffer was then changed to IB with an EGTA-
buffered [Ca2+] of 4 mM (Figure 2E) or 1 mM (Figure 2F), eliciting
a gradual rise in [Ca2+]m that reached a plateau value of
w80 and w20, respectively. At both buffered [Ca2+], miR-25
Figure 2. miR-25 Inhibits Mitochondrial Ca2+
Uptake without Causing Morphological Rear-
rangement or Changes in the Electrochemical
Gradient
(A) Cytosolic Ca2+ concentration peaks: Ctrl miR:
1.72 6 0.25 mM; miR-25: 1.726 6 0.08 mM. n = 12
independent experiments.
(B) Reticular Ca2+ concentration levels: Ctrl miR:
328.2 6 19.68 mM; miR-25: 319.4 6 13.18 mM.
n = 12 independent experiments.
(C) TMRM fluorescence measurements: miR-25-
expressing HeLa cells show no difference in
TMRM loading (22.25 6 1.18% compared to
control cells). a.u., arbitrary units. n = 32 indepen-
dent experiments.
(D) Fluorescence images of mtDsRed- and
erGFP-labeled mitochondria and ER, respec-
tively, in control- and miR-25-expressing HeLa
cells. Mitochondrial volume and number were
deduced by calculating object size (Ctrl miR:
191.49 6 54.64 mm3; miR-25: 221.16 6 74.4 mm3)
and number (Ctrl miR: 115.56 6 49 mm3; miR-25:
151.67 6 63.2 mm3). ER/mitochondria colocaliza-
tion was estimated by the average volume
of overlapping areas (Ctrl miR: 267.89 6
123.93 mm3; miR-25: 230.7 6 103.26 mm3).
n = 10 independent experiments.
(E and F) [Ca2+]m in permeabilized cells stimu-
lated with 4 mM (mitochondrial Ca2+ uptake rate:
Ctrl miR: 11.44 6 0.49 mM/s; miR-25: 6.01 6
0.31 mM/s; E) or 1 mM (mitochondrial Ca2+ uptake
rate: Ctrl miR: 0.61 6 0.04 mM/s; miR-25: 0.32 6
0.01 mM/s; F) EGTA-buffered fixed [Ca2+]. n = 14
independent experiments.
*p < 0.05; error bars correspond to mean6 SEM.
See also Figure S2.
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accumulation into mitochondria.
Mitochondrial Ca2+ alterations induced by miR-25 could be
reverted by MCU re-expression in miR-25-expressing cells
(Figure S2A) and, accordingly, this rescued Ca2+ affinity
was mirrored in enhanced susceptibility to Ca2+-dependent
apoptosis (Figure S2B). Moreover, 22Rv1 prostatic cells,
which possess very high levels of miR-25 (see Figure 3),
were strongly sensitized to apoptosis after MCU overexpres-
sion (Figure S2C). The increased ability of mitochondria to
accumulate Ca2+ is a fundamental aspect in MCU-related
promotion of cell death: indeed, apoptosis induction observed
in MCU-overexpressing HeLa cells was almost abolished in
the presence of intracellular Ca2+ buffer BAPTA (Figure S2D).
Finally, although miR-25 has also been reported to exert
antiapoptotic effects via interference with the expression of
proapoptotic proteins, such as Bim [22], TRAIL [23], and
PTEN [24], these results show how MCU can be considered a
fundamental target of miR-25-dependent apoptosis inhibition.
Inhibition of MCU Levels by miR-25 Is a Key Aspect in
Human Colon Cancer Progression
We then extended the analysis to cancer cells and tissues. We
first evaluated cell lines derived from human carcinomas, inwhich miR-25 was reported to be highly
expressed [24–26]. Both in PC3, LnCaP,
and 22Rv1 (derived from prostate can-
cer) and in HCT116, RKO, SW80, and
WiDr (derived from colon cancer) cell
lines, we detected an inverse correlationbetween miR-25 levels and MCU mRNA expression, with high
miR-25 levels and low MCU expression levels in cancer lines,
compared to primary nonneoplastic cells (Figure 3A). We
then directly investigated human poorly differentiated colonic
adenocarcinoma samples by immunohistochemistry and
microarray. Also in this case, a significant difference in miR-
25 expression levels was detected (Figure 3B), which corre-
lates with a downregulation of MCU expression. Indeed, in
colonic adenocarcinoma samples with high miR-25 expres-
sion levels, MCU was virtually undetectable by immunohisto-
chemistry in cancerous tissues, compared to relatively high
protein abundance in the normal mucosa (Figure 3C).
To validate that miR-25 exerts its biological activity through
its effect on MCU, we transfected HeLa cells with short hairpin
RNA (shRNA) targeting MCU: as for miR-25, shRNA-MCU
decreases MCU abundance and increases proliferation (Fig-
ure S3A), indicating that MCU targeting is important for the
growth-promoting activity of miR-25. We also tested the ability
of MCU to inhibit the proliferation. We generated PC3 cells that
stably expressedaMCU-FLAG-taggedconstruct (MCU-FLAG),
in whichMCU level and activity was increased relative to that in
empty vector (pcDNA3) stable clones (Figures S3B and S3C),
and found that they formed lower numbers of colonies in soft
agar compared to control pcDNA3 stable clones (Figure S3D).
Figure 3. Inhibition of MCU Levels by miR-25
Is a Key Aspect in Human Colon Cancer
Progression
(A) miR-25 and MCU mRNA expression levels
were analyzed by quantitative real-time PCR in
three prostate cancer (PC3, 22Rv1, LnCaP), four
colon cancer (HCT116, RKO, SW80, WiDr), and
primary nonneoplastic cell lines. RNU6B and
18S expression were used to normalize miR-
25 and MCU expression results, respectively,
for each sample. Primary nonneoplastic cells
present very low abundance of miR-25 and high
MCU levels, whereas cancer lines are character-
ized by inverse correlation between miR-25
levels and MCU mRNA expression. Error bars
correspond to mean6 SEM of n = 3 independent
experiments.
(B) miRNA expression was assessed in 44
normal mucosa samples and 59 stage 2–3 CRC
samples via microarray. The graph shows the
average expression level of miR-25 in both
groups. miR-25 was significantly overexpressed
in cancer samples, as compared to normal
mucosa (p < 0.0001).
(C) Upper row: normal colonic mucosa (routinely
stained with hematoxylin and eosin, at left)
demonstrated strong cytoplasmic granular
reactivity with the anti-MCU antibody (immuno-
peroxidase staining performed on formalin-fixed
paraffin-embedded tissue sections, at right).
Lower row: poorly differentiated colonic adeno-
carcinoma with solid pattern of growth (hema-
toxylin and eosin, at left) showing low level of reactivity with the anti-MCU antibody (immunoperoxidase staining, at right). Two neoplastic cells with
cytoplasmic immunoreactivity of moderate intensity can be observed.
See also Figure S3.
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of mitochondrial Ca2+ uptake, and the ensuing resistance to
apoptosis, could be specifically reversed in cancer cells. For
this purpose, we overexpressed anti-miR-25 in the PC3
and HCT116 cells lines investigated in Figure 3. In both cell
types, anti-miR-25 expression caused an w40% increase in
the [Ca2+]m rise evoked by 100 mM ATP (Figures 4A and 4B).
Accordingly, sensitivity to C2-ceramide and H2O2 were en-
hanced, as revealed by the lower viability (Figures 4C and
4D) and increased PARP and caspase-3 cleavage (Figures
4E and 4F) detected in anti-miR-25-expressing cells. These
data were also confirmed measuring cellular positivity to
annexin V (Figures S4A and S4B).
Overall, the data identify a microRNA (miR-25), highly ex-
pressed in cancer cells, that by targeting the newly discovered
calcium channel of mitochondria reduces the sensitivity of
cancer cells to apoptotic agents. This not only represents
conclusive evidence of the key role of organelle Ca2+ accumu-
lation in the mitochondria-dependent apoptotic routes but
also highlights a novel, unexpected target in cancer therapy.
Now, the exciting task of unveiling the structural and functional
properties of this long-awaited component of the calcium
signalingmachinery of the cell finds an immediate translational
application in a disease area of paramount importance.
Experimental Procedures
Cell Culture and Transient Transfection
HeLa, Hek293, HCT116, and RKO cells were cultured in Dulbecco’s modi-
fied Eagle’smedium supplementedwith 10% fetal calf serum (FCS), L-gluta-
mine, and penicillin/streptomycin in 75 cm2 Falcon flasks. PC3, 22Rv1, and
LnCaP cells were cultured in RPMI 1640, supplemented with 10% FCS,
2 mM L-glutamine, and penicillin/streptomycin, in 75 cm2 Falcon flasks.For aequorin experiments, cells were seeded onto 13mmglass coverslips
and allowed to grow to 75% confluence; for microscopy counts of cell
viability, mitochondrial/reticular morphology analysis, and mitochondrial
membrane potential measurements, cells were seeded on 24 mm glass
coverslip in the same growth conditions.
Lipofectamine 2000 was used as transfectant according to the manufac-
turer’s recommendations. For aequorinmeasurements, we usedmtAEQmut
for HeLa cells andmtAEQ for PC3 andHCT116 cells. All measurements were
performed 24 hr after transfection. All miR and anti-miR molecules (hsa-
miRNA precursor and hsa-miRNA inhibitor) were purchased from Ambion.
shRNA targeting MCU (TRCN0000133861) was purchased from Sigma-
Aldrich.
Vectors and Luciferase Assay
Portions of 30 UTR of human MCU and MICU1 genes, containing miR-25
putative target regions, were amplified through PCR; primers are indicated
in Supplemental Experimental Procedures.
Real-Time RT-PCR to Evaluate miRNA and mRNA Expression
Total RNA was extracted from cells with TRIzol reagent (Invitrogen) accord-
ing to the manufacturer’s instructions (see Supplemental Experimental
Procedures).
Aequorin Measurements
Probes employed were chimeric aequorins targeted to the endoplasmic
reticulum (erAEQmut), cytosol (cytAEQ), and mitochondria (mtAEQmut).
‘‘AEQ’’ refers to wild-type aequorin, and ‘‘AEQmut’’ refers to a low-affinity
D119A mutant of aequorin, as described previously (see Supplemental
Experimental Procedures and [15]).
Immunoblotting
Total cell lysates were prepared in RIPA buffer, and standard immunoblot-
ting procedures were used (Supplemental Experimental Procedures).
Apoptosis Assay
After 24 hr transfection with the indicated miR, cells were treated with
apoptotic stimuli (H2O2, C2-ceramide, or staurosporine), washed three
Figure 4. Regulation of miR-25 Levels Strongly
Sensitizes Cells to Ca2+-Dependent Apoptotic
Stimuli
(A) [Ca2+]m peaks in PC3 cells: Ctrl miR: 5.25 6
0.59 mM; anti-miR-25: 7.816 0.64 mM. n = 16 inde-
pendent experiments.
(B) [Ca2+]m peaks in HCT116 cells: Ctrl miR:
2.28 6 0.21 mM; anti-miR-25: 3.32 6 0.31 mM.
n = 16 independent experiments.
(C and D) Microscopy counts of cell viability in
PC3 (C) and HCT116 (D) cells. Treatments with
H2O2 (500 mM for 2 hr) and C2-ceramide (C2-
cer.; 40 mM for 2 hr) reveal a more efficient
apoptosis induction after anti-miR-25 transfec-
tion. n = 3 independent experiments.
(E and F) Immunoblot shows increased levels of
cleaved PARP and cleaved caspase-3 in anti-
miR-25-expressing PC3 (E) and HCT116 (F)
cells after treatment with C2-ceramide (C2-cer.;
40 mM for 2 hr).
*p < 0.05; error bars correspond to mean 6 SEM.
See also Figure S4.
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62times in PBS, and then fixed with 4% formaldehyde for 10 min at room
temperature (RT). Cells were rinsed with PBS, and 0.1 mg/ml DAPI was
added for 10 min at RT. After washing with PBS, the cells were detected
with fluorescence microscopy, and cells with condensed and/or frag-
mented chromatin indicative of apoptosis were not counted as living cells.
250 fields per well were counted using a Scan^r high-content-throughput
system (Olympus).
Immunohistochemistry
Sections (4 mm thick) were cut from formalin-fixed paraffin-embedded
blocks. One section for each block was routinely stained with hema-
toxylin and eosin for histological examination (Supplemental Experimental
Procedures).
Microarray and Data Analysis
RNA labeling and hybridization on microRNA microarray chips (ArrayEx-
press accession number A-MEXP-258) were performed as described previ-
ously [25]. Raw data were normalized and analyzed in GeneSpring GX
software version 7.3 (Silicon Genetics or Agilent Technologies). Values
below 0.01 were set to 0.01. Each measurement was divided by the 50th
percentile of all measurements in that sample. GeneSpring software gener-
ated a unique value for each miRNA, performing the average of four probes.
Graphs and statistical analyses were performed using GraphPad Prism
5 software.
Supplemental Information
Supplemental Information includes four figures, one table, and Supple-
mental Experimental Procedures and can be found with this article online
at http://dx.doi.org/10.1016/j.cub.2012.11.026.
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